News
Engineered Receptors Help the Immune System Home in on Cancer
Most cancer treatments – from chemotherapies to engineered immune cells – have a host of side effects, in large part because they affect healthy cells in the body at the same time as targeting tumor cells. For the same reason, designing new cancer drugs can be challenging due to the molecular
Curiosity and the Pursuit of Scientific Discovery: Q&A with Alex Lee, PhD
Alex Lee, PhD, a bioinformatician in the Sweet-Cordero lab, recently received an R50 training grant from the NCI. This salary-based award, which received a perfect score from reviewers, will allow Lee to explore additional research interests and collaborate with other labs in addition to his regular
This AI Tool Helps Neurosurgeons Find Sneaky Cancer Cells
When brain tumors recur, survival rates go down, and patients with the most lethal tumor type often die within a year. That’s because cancerous tissue is left behind after the initial surgery, and it continues to grow, sometimes even faster than the original tumor. Now a new study, led by UC San
New Study Looks at Why Cancer Treatments Cause Heart Damage
New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new discipline in medicine, called cardio-oncology. Now teams from UC San Francisco and Stanford University
Prioritizing Organ Preservation for Rectal Cancer Patients
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering consequences associated with traditional rectal surgery, physicians are increasingly using treatment
Dr. Samuel Washington Wins 2024 PCF Young Investigator Award
The Prostate Cancer Foundation (PCF) aims to find future research leaders to bring new ideas and new scientific discoveries to prostate cancer research through its Young Investigator Awards program. Dr. Washington, an Assistant Professor in the Urology Department at UCSF, has received the 2024 PCF
Katherine Van Loon Named Editor-in-Chief of JCO Global Oncology
Katherine Van Loon, MD, MPH, has been appointed as the next editor-in-chief of JCO Global Oncology ( JCO GO), an American Society of Clinical Oncology (ASCO) journal. JCO GO is an online only open access journal focusing on cancer research, care and delivery in low-resource countries and settings